Nifty
Sensex
:
:
17800.30
60093.00
138.15 (0.78%)
543.10 (0.91%)

Pharmaceuticals & Drugs - Global

Rating :
31/99

BSE: 524816 | NSE: NATCOPHARM

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 9,733.04
  • 23.99
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 9,930.94
  • 0.84%
  • 2.14

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 48.82%
  • 3.07%
  • 19.83%
  • FII
  • DII
  • Others
  • 11.72%
  • 14.36%
  • 2.20%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.40
  • -2.30
  • 0.52

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.80
  • -22.27
  • -14.67

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.99
  • -24.57
  • -28.28

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.41
  • 25.83
  • 36.83

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.20
  • 3.57
  • 3.47

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.78
  • 19.52
  • 23.82

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Net Sales
432.10
377.20
14.55%
884.60
410.30
115.60%
596.80
331.30
80.14%
560.50
355.20
57.80%
Expenses
336.80
306.70
9.81%
489.30
300.50
62.83%
615.40
255.10
141.24%
458.70
272.70
68.21%
EBITDA
95.30
70.50
35.18%
395.30
109.80
260.02%
-18.60
76.20
-
101.80
82.50
23.39%
EBIDTM
22.06%
18.69%
44.69%
26.76%
-3.12%
23.00%
18.16%
23.23%
Other Income
20.50
38.00
-46.05%
34.30
17.00
101.76%
13.80
28.40
-51.41%
30.20
30.80
-1.95%
Interest
3.80
4.00
-5.00%
4.20
2.00
110.00%
6.70
3.50
91.43%
5.00
3.40
47.06%
Depreciation
41.70
34.70
20.17%
39.60
33.80
17.16%
38.10
30.40
25.33%
36.00
29.80
20.81%
PBT
70.30
69.80
0.72%
385.80
91.00
323.96%
-49.60
70.70
-
91.00
80.10
13.61%
Tax
13.50
4.70
187.23%
65.40
16.00
308.75%
0.90
17.70
-94.92%
10.60
16.70
-36.53%
PAT
56.80
65.10
-12.75%
320.40
75.00
327.20%
-50.50
53.00
-
80.40
63.40
26.81%
PATM
13.15%
17.26%
36.22%
18.28%
-8.46%
16.00%
14.34%
17.85%
EPS
3.11
3.57
-12.89%
17.56
4.11
327.25%
-2.77
2.90
-
4.41
3.45
27.83%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
2,474.00
1,944.80
2,052.10
1,915.00
2,094.50
2,184.80
2,020.20
1,141.30
825.28
738.89
660.53
Net Sales Growth
67.84%
-5.23%
7.16%
-8.57%
-4.13%
8.15%
77.01%
38.29%
11.69%
11.86%
 
Cost Of Goods Sold
642.80
528.40
483.70
354.40
332.70
411.10
599.10
341.10
242.37
233.23
242.80
Gross Profit
1,831.20
1,416.40
1,568.40
1,560.60
1,761.80
1,773.70
1,421.10
800.20
582.90
505.67
417.73
GP Margin
74.02%
72.83%
76.43%
81.49%
84.12%
81.18%
70.34%
70.11%
70.63%
68.44%
63.24%
Total Expenditure
1,900.20
1,681.30
1,448.30
1,332.40
1,299.70
1,256.40
1,336.80
868.70
611.90
559.56
510.60
Power & Fuel Cost
-
76.40
61.10
62.40
59.60
56.20
50.50
43.70
43.24
44.77
38.75
% Of Sales
-
3.93%
2.98%
3.26%
2.85%
2.57%
2.50%
3.83%
5.24%
6.06%
5.87%
Employee Cost
-
444.80
414.90
375.00
355.90
325.60
243.20
189.60
136.92
112.77
102.29
% Of Sales
-
22.87%
20.22%
19.58%
16.99%
14.90%
12.04%
16.61%
16.59%
15.26%
15.49%
Manufacturing Exp.
-
344.90
165.70
243.30
276.40
182.60
141.20
105.20
73.04
76.57
65.10
% Of Sales
-
17.73%
8.07%
12.70%
13.20%
8.36%
6.99%
9.22%
8.85%
10.36%
9.86%
General & Admin Exp.
-
161.50
242.90
132.60
126.40
105.50
88.10
73.40
63.66
56.21
39.49
% Of Sales
-
8.30%
11.84%
6.92%
6.03%
4.83%
4.36%
6.43%
7.71%
7.61%
5.98%
Selling & Distn. Exp.
-
43.70
34.40
98.10
90.00
136.90
143.20
91.60
37.36
26.16
14.82
% Of Sales
-
2.25%
1.68%
5.12%
4.30%
6.27%
7.09%
8.03%
4.53%
3.54%
2.24%
Miscellaneous Exp.
-
81.60
45.60
66.60
58.70
38.50
71.50
24.10
15.31
9.85
14.82
% Of Sales
-
4.20%
2.22%
3.48%
2.80%
1.76%
3.54%
2.11%
1.86%
1.33%
1.11%
EBITDA
573.80
263.50
603.80
582.60
794.80
928.40
683.40
272.60
213.38
179.33
149.93
EBITDA Margin
23.19%
13.55%
29.42%
30.42%
37.95%
42.49%
33.83%
23.89%
25.86%
24.27%
22.70%
Other Income
98.80
99.00
106.00
107.40
130.20
40.40
13.90
9.90
14.91
16.71
12.41
Interest
19.70
17.70
13.30
21.50
19.30
15.40
18.50
22.90
31.68
36.62
26.31
Depreciation
155.40
142.60
116.90
99.80
81.00
66.20
54.40
51.00
47.27
30.44
22.12
PBT
497.50
202.20
579.60
568.70
824.70
887.20
624.40
208.60
149.34
128.98
113.90
Tax
90.40
32.20
137.20
110.60
182.30
192.00
139.50
52.80
3.95
30.87
36.44
Tax Rate
18.17%
15.92%
23.67%
19.45%
22.11%
21.64%
22.34%
25.31%
2.94%
23.93%
35.61%
PAT
407.10
170.00
440.90
460.80
644.40
696.20
486.00
157.10
134.62
102.74
71.87
PAT before Minority Interest
407.10
170.00
442.40
458.10
642.40
695.20
484.90
155.80
130.27
98.11
65.88
Minority Interest
0.00
0.00
-1.50
2.70
2.00
1.00
1.10
1.30
4.35
4.63
5.99
PAT Margin
16.46%
8.74%
21.49%
24.06%
30.77%
31.87%
24.06%
13.77%
16.31%
13.90%
10.88%
PAT Growth
58.71%
-61.44%
-4.32%
-28.49%
-7.44%
43.25%
209.36%
16.70%
31.03%
42.95%
 
EPS
22.29
9.31
24.15
25.24
35.29
38.13
26.62
8.60
7.37
5.63
3.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
4,263.60
4,121.60
3,773.50
3,489.00
3,072.20
1,649.30
1,295.70
846.05
725.88
533.54
Share Capital
36.50
36.50
36.40
36.50
36.90
34.90
34.80
33.23
33.07
31.37
Total Reserves
4,223.70
4,067.60
3,713.60
3,421.70
3,011.40
1,599.00
1,251.20
812.82
692.80
502.17
Non-Current Liabilities
135.10
142.90
117.80
83.40
47.10
37.70
28.00
119.23
150.67
191.46
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
94.03
92.20
135.62
Unsecured Loans
0.00
0.00
0.90
0.00
0.00
0.00
0.00
2.99
3.28
2.21
Long Term Provisions
95.70
99.60
90.20
71.00
32.40
21.90
12.50
9.50
11.09
8.62
Current Liabilities
710.40
525.60
685.30
728.70
592.00
626.50
493.10
413.74
312.28
344.87
Trade Payables
161.80
146.20
255.40
217.00
269.10
262.70
275.60
125.30
109.79
105.85
Other Current Liabilities
126.70
99.50
95.90
109.80
133.40
127.10
114.20
118.56
102.18
90.21
Short Term Borrowings
404.00
265.80
315.00
386.30
173.20
221.60
98.40
168.54
98.63
147.74
Short Term Provisions
17.90
14.10
19.00
15.60
16.30
15.10
4.90
1.33
1.69
1.07
Total Liabilities
5,109.10
4,791.90
4,587.80
4,303.10
3,715.10
2,317.60
1,821.70
1,384.05
1,195.71
1,080.41
Net Block
2,311.80
2,023.20
1,584.40
1,227.20
1,018.60
833.00
710.10
709.97
644.74
582.75
Gross Block
3,126.90
2,702.10
2,148.70
1,694.50
1,407.60
1,158.70
983.30
939.98
819.89
726.97
Accumulated Depreciation
815.10
678.90
564.30
467.30
389.00
325.70
273.20
225.82
171.11
140.57
Non Current Assets
2,611.90
2,447.10
2,262.20
1,955.90
1,584.40
1,230.30
984.70
901.08
827.57
749.94
Capital Work in Progress
129.50
223.40
518.00
637.60
480.00
336.30
211.80
128.96
123.78
105.84
Non Current Investment
104.40
151.90
83.60
19.90
8.10
0.10
0.10
1.57
1.57
1.54
Long Term Loans & Adv.
61.50
44.30
72.00
62.80
75.40
60.40
62.10
57.03
54.25
57.20
Other Non Current Assets
4.70
4.30
4.20
8.40
2.30
0.50
0.60
3.54
3.24
2.61
Current Assets
2,497.20
2,344.80
2,325.60
2,347.20
2,130.70
1,087.30
837.00
482.97
368.14
330.48
Current Investments
203.70
151.80
28.70
148.70
68.40
32.10
22.10
0.12
0.32
0.81
Inventories
762.00
798.20
558.00
529.00
438.40
348.90
357.30
220.00
181.12
146.02
Sundry Debtors
620.60
412.90
551.30
506.20
637.50
475.20
261.60
192.43
118.80
129.71
Cash & Bank
206.10
283.50
66.00
279.50
183.70
35.80
45.20
13.36
11.05
10.78
Other Current Assets
704.80
94.70
91.60
107.40
802.70
195.30
150.80
57.06
56.85
43.14
Short Term Loans & Adv.
616.70
603.70
1,030.00
776.40
749.50
169.50
125.40
40.97
52.46
38.85
Net Current Assets
1,786.80
1,819.20
1,640.30
1,618.50
1,538.70
460.80
343.90
69.23
55.85
-14.39
Total Assets
5,109.10
4,791.90
4,587.80
4,303.10
3,715.10
2,317.60
1,821.70
1,384.05
1,195.71
1,080.42

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
46.50
298.80
417.30
668.80
463.60
345.80
112.20
92.67
144.03
61.19
PBT
202.20
579.60
568.70
824.70
887.20
624.40
208.60
134.22
128.98
102.32
Adjustment
123.90
62.10
54.00
14.30
75.60
100.20
90.50
68.14
65.72
48.87
Changes in Working Capital
-231.40
-212.90
-97.60
8.60
-294.60
-253.00
-140.70
-85.96
-16.11
-67.39
Cash after chg. in Working capital
94.70
428.80
525.10
847.60
668.20
471.60
158.40
116.41
178.58
83.80
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-48.20
-130.00
-107.80
-178.80
-204.60
-125.80
-46.20
-23.74
-34.55
-22.61
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5.30
-103.30
-167.00
-612.20
-1,115.50
-299.40
-175.50
-114.75
-108.92
-107.07
Net Fixed Assets
-204.80
-250.20
-335.80
-436.10
-392.40
-299.40
-303.91
-100.13
-99.70
-102.47
Net Investments
-213.00
-145.90
53.30
-94.80
-54.80
-1.00
37.47
-42.37
-11.33
-2.67
Others
412.50
292.80
115.50
-81.30
-668.30
1.00
90.94
27.75
2.11
-1.93
Cash from Financing Activity
34.80
-185.70
-250.80
-50.90
650.90
-47.70
154.00
29.07
-35.27
26.31
Net Cash Inflow / Outflow
76.00
9.80
-0.50
5.70
-1.00
-1.30
90.70
6.99
-0.15
-19.57
Opening Cash & Equivalents
25.80
19.80
28.30
21.70
23.50
24.20
-164.10
10.22
9.95
34.64
Closing Cash & Equivalent
111.10
25.80
19.80
28.30
21.70
23.50
-74.20
12.44
10.22
9.95

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
233.44
224.88
206.04
189.49
165.22
93.63
73.91
50.91
219.48
170.06
ROA
3.43%
9.43%
10.30%
16.02%
23.05%
23.43%
9.72%
10.10%
8.62%
6.64%
ROE
4.06%
11.27%
12.71%
19.75%
29.70%
33.21%
14.62%
16.57%
15.58%
13.08%
ROCE
4.86%
13.99%
14.82%
23.71%
35.28%
39.21%
18.04%
15.62%
18.02%
16.04%
Fixed Asset Turnover
0.76
0.86
1.07
1.47
1.72
1.93
1.23
0.95
0.96
1.14
Receivable days
85.10
84.44
93.77
91.36
92.22
65.12
70.27
67.76
60.90
61.30
Inventory Days
128.47
118.77
96.38
77.28
65.25
62.41
89.35
87.33
80.17
70.04
Payable days
106.38
151.52
65.96
72.53
81.42
78.30
85.42
73.36
74.09
73.36
Cash Conversion Cycle
107.20
51.68
124.19
96.11
76.05
49.23
74.21
81.73
66.99
57.98
Total Debt/Equity
0.09
0.06
0.08
0.11
0.06
0.14
0.09
0.37
0.33
0.63
Interest Cover
12.42
44.58
27.45
43.73
58.61
34.75
10.11
5.24
4.52
4.89

News Update:


  • Natco Pharma - Quarterly Results
    22nd Nov 2022, 16:26 PM

    Read More
  • Natco Pharma launches first generic version of Pomalyst Capsules in Australian market
    9th Nov 2022, 11:39 AM

    Pomalyst registered sales of $35.6 million in the Australian market for the year ending March 31, 2022 as per industry sales data

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.